Teva is looking to fill any gap when it comes to the new biologics for chronic migraine with the company confirming TGA approval of AJOVY (fremanezumab) ahead of this week's PBAC meeting. …
Latest Video
New Stories
-
Maybe investigate the issue rather than just get rid of it?
June 4, 2020 - - Comment -
Medicines Australia has 'immediate concerns' over 'review and rescind'
June 4, 2020 - - Latest News -
'Project Orbis' review for STA lung cancer therapy
June 4, 2020 - - Latest News -
COVID-19: Investors call for action to protect life sciences
June 4, 2020 - - Latest News -
Chris Bowen slams 'arbitrary deadline' that will 'only worsen' access
June 3, 2020 - - Latest News -
The 'rescind' and 'inactivate' fix to a political problem
June 3, 2020 - - Comment -
PBAC moves to review and 'rescind' recommendations
June 3, 2020 - - Latest News